Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood : Towards First Tier Screening and Beyond

NCT03831256 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT03831256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood : Towards First Tier Screening and Beyond
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 13, 2020
Completion date
June 30, 2025
Enrollment
7,849 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aneuploidy, prenatal disorder